Stay updated on AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Sign up to get notified when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.

Latest updates to the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record’s content and layout appear unchanged.SummaryDifference0.1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the CNGB3 achromatopsia gene-therapy trial is available, with study design, treatment groups, eligibility criteria, outcomes, and locations. It replaces a 403 error page.SummaryDifference58%

- Check18 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies site revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH website transition and says some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.